Evaluation and medical management of the kidney stone patient

Journal of the Canadian Urological Association

Volumn 4, Issue 6, 2010, Pages 375-379

  Paterson, Ryan ^a   Fernandez, Alfonso ^b   Razvi, Hassan ^b   Sutton, Roger ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649959855     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.10166     Document Type: Review

References (41)

1. Assimos DG, Chew B, Hatch M, et al. Evaluation of the Stone Former. In: Stone Disease 2nd International Consultation on Stone Disease. Paris, France: Health Publications; 2008:33-55.
2. Pearle MS, Coe FL, Rodgers A, et al. Medical Management of Urolithiasis. In: Stone Disease 2nd International Consultation on Stone Disease. Paris, France: Health Publications; 2008:59-84.
3. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of followup. J Am Soc Nephrol 2004;15:3225-32.
4. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis:a 5-year randomized prospective study. J Urol 1996;155:839-43.
5. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346:77-84.
6. Borghi L, Meschi T, Guerra A, et al. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 1993;22:S78-S86.
7. Wilson DR, Strauss AL, Manuel MA. Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis. Urol Res 1984;12:39.
8. Ohkawa M, Tokunaga S, Nakashima T, et al. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol 1992;69:571-6.
9. Scholz K, Schwille PO, Sigel A. Double-blind study with thiazide in recurrent calcium nephrolithiasis. J Urol 1982;128:903-7.
10. Laerum S, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 1984;215:383-9.
11. Pearle MS, Roehrborn CG, Pak CY. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 1999;13:679-85.
12. Mortensen JT, Schultz A, Ostergaard AH. Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones. Int Urol Nephrol 1986;18:265-9.
13. Barcelo P, Wuhl O, Servitge I, et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993;150:1761-4.
14. Pak CY, Sakhaee K, Fuller C. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int 1986;30:422-8.
15. Hofbauer J, Hobarth K, Szabo N, et al. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis- a prospective randomized study. Br J Urol 1994;73:362-5.
16. Mattle D, Hess B. Preventive treatment of nephrolithiasis with alkali citrate-a critical review. Urol Res 2005;33:73-9.
17. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
18. Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997;126:497-504.
19. Curhan GC, Willett WC, Knight EL, et al. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med 2004;164:885-91.
20. Curhan GC, Willett WC, Rimm EB, et al. Family history and risk of kidney stones. J Am Soc Nephrol 1997;8:1568-73.
21. Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996;143:240-7.
22. Curhan GC, Willett WC, Speizer FE, et al. Beverage use and risk of kidney stones in women. Ann Intern Med 1998;128:534-40.
23. Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int 2008;73:489-96.
24. Wabner CL, Pak CY. Effect of orange juice consumption on urinary stone risk factors. J Urol 1993;149:1405-8.
25. Odvina CV. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol 2006;1:1269-74.
26. Pak CY, Odvina CV, Pearle MS, et al. Effect of dietary modification on urinary stone risk factors. Kidney Int 2005;68:2264-73.
27. Pak CY, Peterson R, Poindexter JR. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol 2001;165:378-81.
28. Parks JH, Goldfisher E, Asplin JR, et al. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 2002;167:1607-12.
29. Yagisawa T, Chandhoke PS, Fan J. Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 1999;161:1449-52.
30. Ettinger B, Citron JT, Livermore B, et al. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 1988;139:679-84.
31. Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986;315:1386-9.
32. Hosking DH, Erickson SB, Van den Berg CJ, et al. The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 1983;130:1115-8.
33. Trinchieri A, Mandressi A, Luongo P, et al. The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers. Br J Urol 1991;67:230-6.
34. Goldfarb DS, Coe FL, Asplin JR. Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int 2006;69:1041-7.
35. Lindall A, Denneberg T, Edholm E, et al. The effect of sodium intake on cystinuria with and without tiopronin treatment. Nephron 1995;71:407-15.
36. Norman RW, Manette WA. Dietary restriction of sodium as a means of reducing urinary cystine. J Urol 1990;143:1193-5.
37. Rodman JS, Blackburn P, Williams JJ, et al. The effect of dietary protein on cystine excretion in patients with cystinuria. Clin Nephrol 1984;22:273-8.
38. Nakagawa Y, Asplin JR, Goldfarb DS, et al. Clinical use of cystine supersaturation measurements. J Urol 2000;164:1481-5.
39. Brocks P, Dahl C, Wolf H, et al. Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet 1981;2:124-5.
40. Mortensen JT, Schultz A, Ostergaard AH. Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones. Int Urol Nephrol 1986;18:265-9.
41. Robertson WG, Peacock M, Selby PL et al. In: Urolithiasis and Related Clinical Research. Plenum Press, New York, NY; 1985:545-8.